Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,290 | 4,106 | 7,812 | 2,443 | N/A |
| Other current assets | 110 | 246 | 359 | 414 | 0 |
| TOTAL | $5,400 | $4,352 | $8,171 | $2,857 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 260 | 191 | N/A | 11 | N/A |
| Other Non-Current Assets | 10 | 0 | 0 | 0 | 0 |
| TOTAL | $270 | $191 | $N/A | $11 | $N/A |
| Total Assets | $5,670 | $4,642 | $8,298 | $2,969 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 590 | 0 | 0 | 0 | 0 |
| TOTAL | $590 | $627 | $1,324 | $129 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $590 | $627 | $1,324 | $129 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 27,200 | 18,558 | 17,626 | 10,835 | N/A |
| Retained earnings | -22,210 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 0 | -14,543 | -11,090 | 0 | 0 |
| TOTAL | $5,080 | $4,015 | $6,536 | $10,835 | $N/A |
| Total Liabilities And Equity | $5,670 | $4,642 | $7,860 | $10,964 | $0 |